EUVIMEDEUVIMED entdecken
CrossrefInfokarte

C-reactive protein–triglyceride–glucose index and advanced cardiovascular-kidney-metabolic syndrome in middle-aged and older adults: A cross-population study

Ming Wu, Qing Zhou, Wenwu Zhou, Xiaolong Ma, Anxing Hou, Fei Chen, Cong Nie, Jiahao Pan

Journal of the Renin-Angiotensin-Aldosterone System · 2026-10 · 27

DOI: 10.1177/14703203261497987 ↗
AbstractBibliografische Angaben

Abstract

Background Cardiovascular–kidney–metabolic (CKM) syndrome integrates metabolic risk, kidney dysfunction and cardiovascular disease. The C-reactive protein–triglyceride–glucose index (CTI) combines inflammatory, lipid and glycaemic measures, but its association with advanced CKM across populations remains unclear. Methods Cross-sectional analyses included adults aged ≥45 years from NHANES 2001–2010 and the 2011 and 2015 CHARLS waves. NHANES included 6290 participants from five consecutive two-year cycles with positive fasting-subsample weights. CHARLS included 19,347 observations from 13,867 participants; models adjusted for survey wave, with standard errors clustered by participant. CTI was examined continuously, per cohort-specific SD, by quartiles and with three-knot restricted cubic splines. Analyses included core and expanded models, sensitivity analyses and comparisons of concurrent discrimination. Results Core-model odds ratios per one-unit higher CTI were 1.76 (95% CI, 1.57–1.98) in NHANES and 2.90 (2.72–3.10) in CHARLS, attenuating to 1.50 (1.30–1.72) and 1.37 (1.26–1.49), respectively, after expanded adjustment. Sensitivity estimates remained positive. Overall spline associations were significant; non-linearity was absent in NHANES (P = 0.384) but present in CHARLS (P = 0.0039). Conclusions Higher CTI was cross-sectionally associated with prevalent advanced CKM. Shared measurement domains and contemporaneous assessment limit causal and prospective interpretation, and the clinical value of CTI remains uncertain.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →